Ahmad, Syed

Implications of Insulin-Like Growth Factor-1 in Skeletal Muscle and Various Diseases

Ahmad, S. S., Ahmad, K., Lee, E. J., Lee, Y.-H., & Choi, I. (2020) · Cells

Muscle Physiology and DisordersGrowth Hormone and Insulin-like Growth Factors

Cited by 202

Myostatin and its Regulation: A Comprehensive Review of Myostatin Inhibiting Strategies

Baig, M. H., Ahmad, K., Moon, J. S., Park, S.-Y., Ho Lim, J., Chun, H. J., Qadri, A. F., Hwang, Y. C., Jan, A. T., Ahmad, S. S., et al. (2022) · Frontiers in Physiology

Muscle Physiology and DisordersTGF-β signaling in diseases

Cited by 135

Old drug new use - Amoxapine and its metabolites as potent bacterial β-glucuronidase inhibitors for alleviating cancer drug toxicity

Kong, R., Liu, T., Zhu, X., Ahmad, S., Williams, A. L., Phan, A. T., Zhao, H., Scott, J. E., Yeh, L.-A., & Wong, S. T. C. (2014) · Clinical Cancer Research

Cancer therapeutics and mechanismsPharmacogenetics and Drug Metabolism

Cited by 90

Potential Repurposing of Known Drugs as Potent Bacterial β-Glucuronidase Inhibitors

Ahmad, S., Hughes, M. A., Yeh, L.-A., & Scott, J. E. (2012) · SLAS Discovery

Pharmacogenetics and Drug MetabolismDrug Transport and Resistance Mechanisms

Cited by 44

A High Throughput Assay for Discovery of Bacterial β-Glucuronidase Inhibitors

Ahmad, S., Hughes, M. A., Lane, K. T., Redinbo, M. R., Yeh, L.-A., & Scott, J. E. (2011) · Current Chemical Genomics

Pharmacogenetics and Drug MetabolismCancer therapeutics and mechanisms

Cited by 29